N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene

C287H347B3Br6Cl8F11N53O39S11 — CID 165036293

IUPACN-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene
SMILESBrCCOCCBr.C=CS(C)(=O)=O.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NCCS(C)(=O)=O)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.COCCNC1CC=C(c2cnc(N)c3c(-c4ccc(NS(=O)(=O)c5ccccc5Cl)c(F)c4)nc(C(C)C)n23)CC1.COCCNC1CC=C(c2cnc(N)c3c(Br)nc(C(C)C)n23)CC1.COCCOS(=O)(=O)C(F)(F)F
InChIInChI=1S/C32H36ClFN6O4S.C31H34ClFN6O3S.C30H34ClFN6O4S2.C30H34ClFN6O3S.C27H28ClFN6O2S.C20H28BrN5O2.C19H26BrN5O.3C18H20BClFNO4S.C18H26BrN5O.C15H20BrN5.C4H8Br2O.C4H7F3O4S.C3H6O2S/c1-18(2)30-38-27(20-12-15-24(23(34)16-20)39-45(42,43)26-9-7-6-8-22(26)33)28-29(35)36-17-25(40(28)30)19-10-13-21(14-11-19)37-31(41)44-32(3,4)5;1-19(2)31-36-28(21-9-12-25(24(33)17-21)37-43(40,41)27-6-4-3-5-23(27)32)29-30(34)35-18-26(39(29)31)20-7-10-22(11-8-20)38-13-15-42-16-14-38;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-44(41,42)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-43(3,39)40;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-42(39,40)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-41-3;1-15(2)27-33-24(25-26(31)32-14-22(35(25)27)16-7-10-18(30)11-8-16)17-9-12-21(20(29)13-17)34-38(36,37)23-6-4-3-5-19(23)28;1-11(2)18-25-16(21)15-17(22)23-10-14(26(15)18)12-6-8-13(9-7-12)24-19(27)28-20(3,4)5;1-12(2)19-23-17(20)16-18(21)22-11-15(25(16)19)13-3-5-14(6-4-13)24-7-9-26-10-8-24;3*1-17(2)18(3,4)26-19(25-17)12-9-10-15(14(21)11-12)22-27(23,24)16-8-6-5-7-13(16)20;1-11(2)18-23-16(19)15-17(20)22-10-14(24(15)18)12-4-6-13(7-5-12)21-8-9-25-3;1-8(2)15-20-13(16)12-14(18)19-7-11(21(12)15)9-3-5-10(17)6-4-9;5-1-3-7-4-2-6;1-10-2-3-11-12(8,9)4(5,6)7;1-3-6(2,4)5/h6-10,12,15-18,21,39H,11,13-14H2,1-5H3,(H2,35,36)(H,37,41);3-7,9,12,17-19,22,37H,8,10-11,13-16H2,1-2H3,(H2,34,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);3-7,9,12-15,18,34H,8,10-11,30H2,1-2H3,(H2,31,32);6,10-11,13H,7-9H2,1-5H3,(H2,22,23)(H,24,27);3,11-12,14H,4-10H2,1-2H3,(H2,21,22);3*5-11,22H,1-4H3;4,10-11,13,21H,5-9H2,1-3H3,(H2,20,22);3,7-8,10H,4-6,17H2,1-2H3,(H2,18,19);1-4H2;2-3H2,1H3;3H,1H2,2H3
InChIKeyNKTXMJPJJHUPOB-UHFFFAOYSA-N
MW6520.46 g/mol
LogP57.63
Rot. Bonds75

About N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene

N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene (PubChem CID 165036293) has the molecular formula C287H347B3Br6Cl8F11N53O39S11 and a molecular weight of 6520.46 g/mol. Its IUPAC name is N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene.

Molecular Properties

Compound NameN-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene
PubChem CID165036293
Molecular FormulaC287H347B3Br6Cl8F11N53O39S11
Molecular Weight6520.46 g/mol
Exact Mass6506.64
IUPAC NameN-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene
SMILESBrCCOCCBr.C=CS(C)(=O)=O.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NCCS(C)(=O)=O)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.COCCNC1CC=C(c2cnc(N)c3c(-c4ccc(NS(=O)(=O)c5ccccc5Cl)c(F)c4)nc(C(C)C)n23)CC1.COCCNC1CC=C(c2cnc(N)c3c(Br)nc(C(C)C)n23)CC1.COCCOS(=O)(=O)C(F)(F)F
InChIInChI=1S/C32H36ClFN6O4S.C31H34ClFN6O3S.C30H34ClFN6O4S2.C30H34ClFN6O3S.C27H28ClFN6O2S.C20H28BrN5O2.C19H26BrN5O.3C18H20BClFNO4S.C18H26BrN5O.C15H20BrN5.C4H8Br2O.C4H7F3O4S.C3H6O2S/c1-18(2)30-38-27(20-12-15-24(23(34)16-20)39-45(42,43)26-9-7-6-8-22(26)33)28-29(35)36-17-25(40(28)30)19-10-13-21(14-11-19)37-31(41)44-32(3,4)5;1-19(2)31-36-28(21-9-12-25(24(33)17-21)37-43(40,41)27-6-4-3-5-23(27)32)29-30(34)35-18-26(39(29)31)20-7-10-22(11-8-20)38-13-15-42-16-14-38;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-44(41,42)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-43(3,39)40;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-42(39,40)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-41-3;1-15(2)27-33-24(25-26(31)32-14-22(35(25)27)16-7-10-18(30)11-8-16)17-9-12-21(20(29)13-17)34-38(36,37)23-6-4-3-5-19(23)28;1-11(2)18-25-16(21)15-17(22)23-10-14(26(15)18)12-6-8-13(9-7-12)24-19(27)28-20(3,4)5;1-12(2)19-23-17(20)16-18(21)22-11-15(25(16)19)13-3-5-14(6-4-13)24-7-9-26-10-8-24;3*1-17(2)18(3,4)26-19(25-17)12-9-10-15(14(21)11-12)22-27(23,24)16-8-6-5-7-13(16)20;1-11(2)18-23-16(19)15-17(20)22-10-14(24(15)18)12-4-6-13(7-5-12)21-8-9-25-3;1-8(2)15-20-13(16)12-14(18)19-7-11(21(12)15)9-3-5-10(17)6-4-9;5-1-3-7-4-2-6;1-10-2-3-11-12(8,9)4(5,6)7;1-3-6(2,4)5/h6-10,12,15-18,21,39H,11,13-14H2,1-5H3,(H2,35,36)(H,37,41);3-7,9,12,17-19,22,37H,8,10-11,13-16H2,1-2H3,(H2,34,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);3-7,9,12-15,18,34H,8,10-11,30H2,1-2H3,(H2,31,32);6,10-11,13H,7-9H2,1-5H3,(H2,22,23)(H,24,27);3,11-12,14H,4-10H2,1-2H3,(H2,21,22);3*5-11,22H,1-4H3;4,10-11,13,21H,5-9H2,1-3H3,(H2,20,22);3,7-8,10H,4-6,17H2,1-2H3,(H2,18,19);1-4H2;2-3H2,1H3;3H,1H2,2H3
InChIKeyNKTXMJPJJHUPOB-UHFFFAOYSA-N
XLogP57.63
TPSA1268.93 Ų
H-Bond Donors24
H-Bond Acceptors82
Rotatable Bonds75
Heavy Atoms418
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5006520.46
LogP ≤ 557.63
H-Bond Donors ≤ 524
H-Bond Acceptors ≤ 1082

Analyze N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene?
The IUPAC name of N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene (CID 165036293) is N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene.
What is the SMILES notation for N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene?
The canonical SMILES for N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene is BrCCOCCBr.C=CS(C)(=O)=O.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC(C)c1nc(-c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)c2c(N)ncc(C3=CCC(NCCS(C)(=O)=O)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(N4CCOCC4)CC3)n12.CC(C)c1nc(Br)c2c(N)ncc(C3=CCC(NC(=O)OC(C)(C)C)CC3)n12.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.CC1(C)OB(c2ccc(NS(=O)(=O)c3ccccc3Cl)c(F)c2)OC1(C)C.COCCNC1CC=C(c2cnc(N)c3c(-c4ccc(NS(=O)(=O)c5ccccc5Cl)c(F)c4)nc(C(C)C)n23)CC1.COCCNC1CC=C(c2cnc(N)c3c(Br)nc(C(C)C)n23)CC1.COCCOS(=O)(=O)C(F)(F)F.
What is the InChIKey of N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene?
The InChIKey is NKTXMJPJJHUPOB-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H36ClFN6O4S.C31H34ClFN6O3S.C30H34ClFN6O4S2.C30H34ClFN6O3S.C27H28ClFN6O2S.C20H28BrN5O2.C19H26BrN5O.3C18H20BClFNO4S.C18H26BrN5O.C15H20BrN5.C4H8Br2O.C4H7F3O4S.C3H6O2S/c1-18(2)30-38-27(20-12-15-24(23(34)16-20)39-45(42,43)26-9-7-6-8-22(26)33)28-29(35)36-17-25(40(28)30)19-10-13-21(14-11-19)37-31(41)44-32(3,4)5;1-19(2)31-36-28(21-9-12-25(24(33)17-21)37-43(40,41)27-6-4-3-5-23(27)32)29-30(34)35-18-26(39(29)31)20-7-10-22(11-8-20)38-13-15-42-16-14-38;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-44(41,42)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-43(3,39)40;1-18(2)30-36-27(20-10-13-24(23(32)16-20)37-42(39,40)26-7-5-4-6-22(26)31)28-29(33)35-17-25(38(28)30)19-8-11-21(12-9-19)34-14-15-41-3;1-15(2)27-33-24(25-26(31)32-14-22(35(25)27)16-7-10-18(30)11-8-16)17-9-12-21(20(29)13-17)34-38(36,37)23-6-4-3-5-19(23)28;1-11(2)18-25-16(21)15-17(22)23-10-14(26(15)18)12-6-8-13(9-7-12)24-19(27)28-20(3,4)5;1-12(2)19-23-17(20)16-18(21)22-11-15(25(16)19)13-3-5-14(6-4-13)24-7-9-26-10-8-24;3*1-17(2)18(3,4)26-19(25-17)12-9-10-15(14(21)11-12)22-27(23,24)16-8-6-5-7-13(16)20;1-11(2)18-23-16(19)15-17(20)22-10-14(24(15)18)12-4-6-13(7-5-12)21-8-9-25-3;1-8(2)15-20-13(16)12-14(18)19-7-11(21(12)15)9-3-5-10(17)6-4-9;5-1-3-7-4-2-6;1-10-2-3-11-12(8,9)4(5,6)7;1-3-6(2,4)5/h6-10,12,15-18,21,39H,11,13-14H2,1-5H3,(H2,35,36)(H,37,41);3-7,9,12,17-19,22,37H,8,10-11,13-16H2,1-2H3,(H2,34,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);4-8,10,13,16-18,21,34,37H,9,11-12,14-15H2,1-3H3,(H2,33,35);3-7,9,12-15,18,34H,8,10-11,30H2,1-2H3,(H2,31,32);6,10-11,13H,7-9H2,1-5H3,(H2,22,23)(H,24,27);3,11-12,14H,4-10H2,1-2H3,(H2,21,22);3*5-11,22H,1-4H3;4,10-11,13,21H,5-9H2,1-3H3,(H2,20,22);3,7-8,10H,4-6,17H2,1-2H3,(H2,18,19);1-4H2;2-3H2,1H3;3H,1H2,2H3.
What are the key properties of N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene?
N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene has a molecular weight of 6520.46 g/mol, XLogP of 57.63, 75 rotatable bonds, 24 hydrogen bond donors, and 82 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[8-amino-5-(4-aminocyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;5-(4-aminocyclohexen-1-yl)-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;N-[4-[8-amino-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-[4-(2-methylsulfonylethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;N-[4-[8-amino-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide;1-bromo-2-(2-bromoethoxy)ethane;1-bromo-5-[4-(2-methoxyethylamino)cyclohexen-1-yl]-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;1-bromo-5-(4-morpholin-4-ylcyclohexen-1-yl)-3-propan-2-ylimidazo[1,5-a]pyrazin-8-amine;tert-butyl N-[4-(8-amino-1-bromo-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl)cyclohex-3-en-1-yl]carbamate;tert-butyl N-[4-[8-amino-1-[4-[(2-chlorophenyl)sulfonylamino]-3-fluorophenyl]-3-propan-2-ylimidazo[1,5-a]pyrazin-5-yl]cyclohex-3-en-1-yl]carbamate;tris(2-chloro-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide);2-methoxyethyl trifluoromethanesulfonate;1-methylsulfonylethene is sourced from PubChem (CID 165036293), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).